On the heels of yesterday’s announcement of positive study data from its phase III protocol for its flagship product Generex Oral-lyn, US-based Generex Biotechnology is updating on the products sales in India, where it is marketed and sold by Indian Pharmaceutical company, Shreya Life Sciences.

More: continued here